Screener
Gilead Sciences GILD EBIT
EBIT at other companies
Other financials
Where this comes from
Calculated from Gilead Sciences’s reported figures.
The source filing: Gilead Sciences’s 10-Q, filed May 7, 2026. Open the filing →
- Filed
- May 7, 2026, 5:12 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000882095-26-000024
FAQ
- What is Gilead Sciences's EBIT?
- Gilead Sciences (GILD) reported EBIT of $2.59B in Q1 2026.
- How has Gilead Sciences's EBIT changed year-over-year?
- Gilead Sciences's EBIT increased by 15.6% year-over-year, from $2.24B to $2.59B.
- What is the long-term trend for Gilead Sciences's EBIT?
- Over 4 years (2021 to 2025), Gilead Sciences's EBIT has grown at a 0.3% compound annual growth rate (CAGR), from $9.92B to $10.02B.
- What does EBIT mean?
- Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.
Ask your AI about Gilead Sciences's ebit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude